Yoji Hamada

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

Yoji Hamada, Jiro Nakamura, Keiji Naruse et al. · Diabetes Care · 2000 · 90 citations · Full text

Polyol Pathway Hyperactivity Is Closely Related to Carnitine Deficiency in the Pathogenesis of Diabetic Neuropathy of Streptozotocin-Diabetic Rats

N. Koh, Fumihiko Sakakibara, Yoji Hamada et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 50 citations

Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.

Norio Hotta, N. Koh, Fumihiko Sakakibara et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 31 citations

Role of PKC and TGF-β Receptor in Glucose-Induced Proliferation of Smooth Muscle Cells

Yutaka Yasuda, Jiro Nakamura, Yoji Hamada et al. · Biochemical and Biophysical Research Communications · 2001 · 29 citations

Signal Transduction, Molecular Physiology, Tgf-β Receptor +10

Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats

Jiro Nakamura, Yoji Hamada, Fumihiko Sakakibara et al. · Diabetes Research and Clinical Practice · 2001 · 27 citations

Neurophysiology, Neuroanatomy, Sucrose-fed Oletf Rats +13